Statistics for Burosumab for the Treatment of Tumor‐Induced Osteomalacia
Total visits
| views | |
|---|---|
| Burosumab for the Treatment of Tumor‐Induced Osteomalacia | 56 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:cec5d940-3f50-4c55-9b46-f4bb5ec36256 | 115 |
| JBMR-36-627.pdf | 63 |
| java.util.UUID:365c7037-7502-432f-afd3-39da17b6f205 | 12 |
| java.util.UUID:4b917248-b682-441a-9da3-bb74f0c28bde | 5 |
Top country views
| views | |
|---|---|
| United States | 48 |
| France | 2 |
| China | 1 |
| South Korea | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Nanterre | 2 |
| Seattle | 2 |
| Washington | 2 |
| Ann Arbor | 1 |
| Baltimore | 1 |
| Beijing | 1 |
| Cambridge | 1 |
| Seoul | 1 |